Valluvan Jeevanandam to Time Factors
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Time Factors.
Connection Strength
0.744
-
Perioperative improvement in serum albumin level in patients with left ventricular assist device. J Card Surg. 2020 Nov; 35(11):3070-3077.
Score: 0.101
-
Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation. Ann Thorac Surg. 2014 Jul; 98(1):81-3.
Score: 0.065
-
Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2010 Jun; 29(6):603-9.
Score: 0.049
-
Outcomes From Three Decades of Infant and Pediatric Heart Transplantation. ASAIO J. 2021 09 01; 67(9):1051-1059.
Score: 0.027
-
Outcomes of Ambulatory Axillary Intraaortic Balloon Pump as a Bridge to Heart Transplantation. Ann Thorac Surg. 2021 04; 111(4):1264-1270.
Score: 0.025
-
Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. Circ Heart Fail. 2020 04; 13(4):e006666.
Score: 0.025
-
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2020 04 07; 9(7):e014801.
Score: 0.024
-
Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
Score: 0.024
-
Increasing heart transplant donor pool by liberalization of size matching. J Heart Lung Transplant. 2019 11; 38(11):1197-1205.
Score: 0.023
-
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
Score: 0.023
-
Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation. J Cardiovasc Electrophysiol. 2019 02; 30(2):183-192.
Score: 0.022
-
Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
Score: 0.022
-
Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Dig Dis Sci. 2018 Jun; 63(6):1518-1524.
Score: 0.021
-
Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
Score: 0.021
-
Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. J Card Fail. 2018 02; 24(2):101-108.
Score: 0.021
-
Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device. ASAIO J. 2017 Nov-Dec; 63(6):745-751.
Score: 0.021
-
Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
Score: 0.020
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
Score: 0.020
-
Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
Score: 0.018
-
Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant. 1994 Jul-Aug; 13(4):681-7; discussion 685-7.
Score: 0.016
-
Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
Score: 0.016
-
Cardiac transplantation after prolonged graft preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg. 1992 Aug; 104(2):224-8.
Score: 0.014
-
Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):951-5.
Score: 0.014
-
Quantifying the incremental cost of complications associated with mitral valve surgery in the United States. J Thorac Cardiovasc Surg. 2012 Apr; 143(4):864-72.
Score: 0.014
-
University of Wisconsin solution for human donor heart preservation: initial clinical experience. Ann Thorac Surg. 1991 Dec; 52(6):1213-6.
Score: 0.014
-
Improved heart preservation with University of Wisconsin solution: experimental and preliminary human experience. Circulation. 1991 Nov; 84(5 Suppl):III324-8.
Score: 0.014
-
Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol. 2010 May 01; 105(9):1339-42.
Score: 0.012
-
Live 3-dimensional transesophageal echocardiography initial experience using the fully-sampled matrix array probe. J Am Coll Cardiol. 2008 Aug 05; 52(6):446-9.
Score: 0.011
-
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008 Oct; 74(8):1059-69.
Score: 0.011
-
Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr. 2003 Nov-Dec; 27(6):396-403.
Score: 0.008
-
Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant. 2001 May; 1(1):89-92.
Score: 0.007
-
Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries). J Immunol. 2000 Sep 15; 165(6):3469-83.
Score: 0.006
-
Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplant Proc. 1998 Aug; 30(5):1892-4.
Score: 0.005
-
Functional and morphologic adaptation of undersized donor hearts after heart transplantation. J Am Coll Cardiol. 1995 Sep; 26(3):737-42.
Score: 0.004
-
Novel preservation solution permits 24-hour preservation in rat and baboon cardiac transplant models. Circulation. 1993 Nov; 88(5 Pt 2):II291-7.
Score: 0.004